Car.70/Il15-Transduced Cb-Nk Cells
T-cell Non-Hodgkin's Lymphoma/ T-cell Acute Lymphoblastic Leukmeia
M.D. Anderson Cancer CenterCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
48 Active assets in the T-cell Non-Hodgkin's Lymphoma/ T-cell Acute Lymphoblastic Leukmeia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Children's Oncology Group | Phase 3 | BB |
Cyclophosphamide Children's Oncology Group | Phase 3 | BB |
Cytosin-Arabinosid Princess Maxima Center for Pediatric Oncology | Phase 3 | BB |
ETOPOSIDE Children's Cancer Group, China | Phase 3 | BB |
Daunorubicin Children's Oncology Group | Phase 3 | B |
View all 50 →
Same molecule, other indications
Car.70/Il15-Transduced Cb-Nk Cells is also rated in:
Myelodysplastic Syndrome / Chronic Myelomonocytic LeukemiaDormant
CCC
Indicative ·
48 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →